The Use of Benralizumab in the Treatment of Near-Fatal Asthma: A New Approach
Sanjay Ramakrishnan(Oxford BioMedica (United Kingdom)), Mona Bafadhel(National Institute for Health and Care Research), Richard Russell(Southern Health NHS Foundation Trust), Bavithra Vijayakumar(Manchester University NHS Foundation Trust), Ian Pavord(Oxford BioMedica (United Kingdom)), James Camp(University of Oxford), M Downs(University of Oxford), F M Hardinge(Oxford University Hospitals NHS Trust)
American Journal of Respiratory and Critical Care Medicine
February 5, 2020
Cited by 24
Related Papers
Control of Confounding and Reporting of Results in Causal Inference Studies. Guidance for Authors from Editors of Respiratory, Sleep, and Critical Care Journals
|Annals of the American Thoracic Society|2018|723
Effectiveness and Safety of Bronchial Thermoplasty in the Treatment of Severe Asthma: A Multicenter, Randomized, Double-Blind, Sham-Controlled Clinical Trial
|American Journal of Respiratory and Critical Care Medicine|2009|686
Blood eosinophil count and prospective annual asthma disease burden: a UK cohort study
|The Lancet Respiratory Medicine|2015|584
Dupilumab for COPD with Type 2 Inflammation Indicated by Eosinophil Counts
|New England Journal of Medicine|2023|452
Inhaled budesonide in the treatment of early COVID-19 (STOIC): a phase 2, open-label, randomised controlled trial
|The Lancet Respiratory Medicine|2021|434